Alnylam Pharmaceuticals (NASDAQ:ALNY): Q1 Non-GAAP EPS of -$1.52 misses by $0.01; GAAP EPS of -$1.62 beats by $0.25.
Revenue of $99.48M (+198.8% Y/Y) beats by $9.03M.
https://seekingalpha.com/news/3569993-alnylam-pharmaceuticals-eps-misses-0_01-beats-on-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.